Optimizing Cigna Fasenra Prior Authorization Workflows
Streamlining Cigna Fasenra prior authorization is critical for timely patient access to this high-volume specialty medication. Klivira provides the automation and connectivity to navigate Cigna Healthcare's specific requirements.
For revenue cycle directors and prior authorization coordinators, managing specialty drug PAs like Fasenra requires precision across diverse payer workflows. Understanding Cigna Healthcare's distinct submission channels, policy application, and appeal processes is key to minimizing delays and reducing administrative burden.
Cigna Fasenra Prior Authorization Submission Channels
Fasenra, a biologic for severe eosinophilic asthma, typically requires prior authorization under both medical and pharmacy benefits. Cigna Healthcare directs medical benefit PA submissions via the CignaforHCP.com provider portal, which supports member lookup, PA initiation, and document uploads. For pharmacy benefit, Express Scripts, operating under the Evernorth brand, manages Fasenra PAs.
Key Submission Pathways for Fasenra with Cigna Healthcare
- Medical Benefit Submissions: Utilize CignaforHCP.com for direct PA initiation and document upload.
- X12 278 Transactions: Accepted via clearinghouses for medical benefit prior authorizations.
- Pharmacy Benefit (Express Scripts): Submissions route through Express Scripts' provider PA system for retail pharmacy benefit.
- ePA via Partners: For prescriber-initiated pharmacy workflows, Express Scripts leverages CoverMyMeds and Surescripts.
- Specialty Pharmacy (Accredo): Accredo, an Evernorth specialty pharmacy, handles specific pharmacy benefit PAs for specialty injectables like Fasenra.
Understanding Cigna Healthcare's Fasenra Coverage Policies
Cigna Healthcare publishes detailed coverage policies and medical-necessity guidelines on its public provider site. These policies outline clinical criteria, step-therapy requirements, and other utilization management rules specific to specialty biologics like Fasenra. Referencing the specific policy number and effective date is crucial for accurate submissions.
Cigna Healthcare Turnaround Timeframes for Fasenra PAs
Prior authorization turnaround times for Cigna Healthcare are governed by applicable state insurance regulations for commercial plans. For Medicare Advantage and Qualified Health Plans on the Federal Facilitated Marketplace, Cigna Healthcare is an impacted payer under CMS-0057-F, which mandates 72-hour standard and 24-hour expedited PA timeframes on its phased compliance timeline.
Electronic Prior Authorization (ePA) for Fasenra with Cigna
Cigna Healthcare participates in the HL7 Da Vinci Project ecosystem, indicating a commitment to advanced electronic data exchange. For pharmacy benefit Fasenra PAs, Express Scripts has well-established ePA capabilities through partners like CoverMyMeds and Surescripts, facilitating streamlined electronic submissions.
Common Denial Patterns and Appeal Pathways for Fasenra
Denials for Fasenra PAs from Cigna Healthcare are often related to medical necessity, insufficient documentation, or failure to meet step-therapy requirements. Site-of-service mismatch or non-formulary pharmacy issues (via Express Scripts) can also occur. Cigna Healthcare provides clear appeal pathways via the provider portal, including peer-to-peer review options for clinical denials.
Frequently asked questions
How do I submit a Fasenra prior authorization request to Cigna Healthcare?
For medical benefit Fasenra PAs, submit through CignaforHCP.com or via X12 278. For pharmacy benefit, requests route through Express Scripts' system, often utilizing ePA partners like CoverMyMeds or Surescripts, or Accredo for specialty pharmacy.
Who manages Fasenra's pharmacy benefit prior authorizations for Cigna members?
Express Scripts, operating under the Evernorth brand, is the PBM responsible for managing pharmacy benefit prior authorizations for Cigna members, including specialty drugs like Fasenra. Accredo, an Evernorth specialty pharmacy, handles specific specialty injectable PAs.
What are common reasons for Cigna Fasenra prior authorization denials?
Common denial reasons include insufficient documentation of medical necessity, failure to demonstrate required preceding therapies (step therapy), inappropriate site of service, or issues with formulary compliance under Express Scripts.
Does Cigna support electronic prior authorization (ePA) for Fasenra?
Yes, for pharmacy benefit Fasenra PAs, Express Scripts supports ePA through established partners like CoverMyMeds and Surescripts. Cigna Healthcare also participates in the Da Vinci Project, indicating ongoing efforts in electronic data exchange for medical benefit PAs.
Where can I find Cigna Healthcare's medical policies for Fasenra?
Cigna Healthcare publishes its coverage policies and medical-necessity guidelines, including those for specialty biologics, on its public provider site. It is essential to reference the specific policy number and effective date.
Related coverage
Other fasenra prior authorization by payer
- Navigating Aetna Fasenra Prior Authorization
- Navigating Anthem (Elevance Health) Fasenra Prior Authorization
- Streamlining Humana Fasenra Prior Authorization Workflows
- Streamlining Medicaid Fasenra Prior Authorization Workflows
- Optimizing Medicare Fasenra Prior Authorization Workflows
- Streamlining UnitedHealthcare Fasenra Prior Authorization
Other fasenra prior authorization by specialty
- Streamlining Fasenra Prior Authorization for Cardiology
- Optimizing Fasenra Prior Authorization for Endocrinology Practices
- Fasenra Prior Authorization for Gastroenterology Simplified
- Fasenra Prior Authorization for Oncology: Navigating Hematology-Oncology Workflows
- Navigating Fasenra Prior Authorization for Orthopedics
Ready to automate prior auth for this drug?
See how Klivira automates prior authorizations for your team.
Request a demo